RSS chief pays tribute to Gauri Lankesh, Dharam Singh

Dubai, Jul 9: Air India Express has opened ticket bookings for flights from India to the UAE from July 12 to 26. The carrier posted the announcement on its social media pages.

“INDIA to UAE - Flights are open for sale! Bookings could be made through our website (http://airindiaexpress.in), call centre or authorised travel agents. Visit http://blog.airindiaexpress.in for more details,” the budget airline tweeted.

A clause mentioned in the flyer attached to the post added that only UAE residents with permits to return from India can book flights.

Thousands of Indian expats have been waiting to book flights back to the UAE after being stuck home for about four months due to the COVID-19 travel restrictions.

Vande Bharat Mission flights

Under the fourth phase of Vande Bharat Mission, as many as 104 flights will be operating between UAE and India. 

The Air India announced this on Twitter under a post “#FlyAI : Important Information for ICA approved UAE residents who wish to travel to UAE on Vande Bharat Mission flights.”

A flyer attached to the post addressed passengers who wish to travel to UAE on flights being operated under Vande Bharat Mission by Air India and Air India Express in pursuance of agreement between Civil Aviation authorities of India and the UAE.

“AI and AIE operating evacuation flights to Indian citizens from the UAE to India will carry ICA approved UAE residents (returning to the UAE from India) on the outward journey from India to the UAE.”

“On the India-UAE journey, all these flights will carry only those passengers who are destined for the UAE.”

“This arrangement will be operational for a period of 15 days from July 12 to 26,” the airline added.

While most of the Vande Bharat flights are operated by AIE, a few flights from Sharjah are operated by Air India.

Thiruvananthapuram, Apr 10: Kerala Chief Minister Pinarayi Vijayan on Friday said that it has been 100 days since the first COVID-19 case was reported and shared the updated figures of positive cases, along with the efforts made by the state government to contain the virus.

"100 Days of #COVID19 | Kerala Story It's been 100 days since the first case was reported. 258 active cases, 97 recovered, Total confirmed: 357 Deaths: 2. 12,710 samples tested Special COVID-19 Hospital, 1,251 Community Kitchens, 28,08,650 Individuals Served, 3,676 Destitutes Rehabilitated," Vijayan tweeted.

India's first case was reported in Kerala in January. The patient was a student, who was studying at Wuhan University in China.

Meanwhile, the Ministry of Health and Family Welfare on Friday informed that India's total number of COVID-19 positive cases now stands at 6,412. Out of these, 5,709 are active patients and 504 of them have been cured/discharged and migrated.

With 30 new deaths reported in the last 12 hours, the death toll has reached 199.

Mangaluru, May 23: Criticising the Karnataka government's fresh protocol for management of Covid-19 as expensive, a prominent physician in the city has demanded its withdrawal.

According to Dr B Srinivas Kakkilaya, the protocol released by the Health and Family Welfare Department on May 15 enlists unnecessary and unconfirmed tests and treatments. 

The protocol has classified Covid-19 cases into three categories and has provided for hospitalisation of all three categories of patients, from asymptomatic to the most severely ill.

In a letter to the government, Dr Kakkilaya said: "The protocol suggests several investigations to be done right on the day of admission, including blood counts, liver and renal function tests, chest X Ray, ECG, CT scan of the chest, and other special investigations, all of which, if done, will cost Rs 25,000 per patient."

"In the coming days when lakhs of patients are likely to be infected with SARS CoV2, is it necessary and feasible to hospitalise and test all these patients at Rs 25,000 per person," he questioned.

The treatment options suggested in the protocol are also surprising, he pointed out. "The protocol recommends choloroquine, azithromycin, oseltamivir, zinc and vitamin C for all patients, from asymptomatic to the severely ill, and also anti coagulant injections for many patients. All these would cost at least Rs 5,000 per patient. For severe cases of Covid-19, many unproven and experimental treatments have been suggested, which are very expensive and highly questionable," Dr Kakkilaya notes.

Therefore, this protocol, he asserted was not evidence based and likely to do more harm than good. He said these unnecessarily expensive tests and allowing private companies to conduct trials on Covid-19 patients is likely to be misused by vested interests and must be immediately withdrawn, and instead, a protocol that is evidence-based, simple and avoiding unnecessary expenses, must be developed.